Back to team page

Katie Leyden

Director

Katie’s background in human-centered design, cultural analysis, and business positions her as both a creative and strategic thinker. She brings a cross-disciplinary understanding to ethnographic research and business analysis and has focused on various sectors including technology, e-commerce, entrepreneurship, and housing. She is driven by the desire to understand why people think the way they do and to find solutions for the everyday inconveniences. Katie graduated with a BA from the University of Notre Dame in American Studies with minors in Business Economics and Collaborative Innovation.

Bold facts

Learn more about

Katie

Something unique about you summed up in one sentence:

If the UV is above a 4, you’ll find me outside no matter what the temperature is.

Your favorite part of working at Bold Insight

The welcoming nature of the Bold Insight team and the constant AHA moments during research when someone explains why they think a certain way about something.

In your spare time (or if you had spare time), you would absolutely do this:

Become a certified yoga instructor.

Your favorite city in the world is...and why?

London, hands down! I spent a semester abroad living, learning, and interning in Central London and I can’t wait to go back.

You cannot start the day without doing this:

Putting oat milk in my smoothie and coffee.

Your ultimate celebrity dinner party guest list would include:

The creators of The Office. It would be spit take central! Note to self: don’t wear white.

Long-term personal or professional goal?

I really want to live in London for a few years… I can’t hold onto studying abroad for too much longer!

Any other facts to share?

I wrote my senior thesis in the middle of the nationwide quarantine and used the walls of my childhood basement for white boarding.
Read Katie's bold insights

Read our team’s latest bold insights

Human factors testing for OTC drugs and non-prescription medical devices

Jan 16, 2025

As the field of human factors continues to evolve, so must our approaches to testing and study design. While the FDA’s 2013 guidance laid the groundwork for study design and methodology, recent discussions and conference presentations have prompted a shift in how we approach OTC HF testing, leading to more comprehensive and realistic assessments of these products.

read more